Home/Filings/4/0000905148-25-000730
4//SEC Filing

Peterson Katharine 4

Accession 0000905148-25-000730

CIK 0001781174other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:00 PM ET

Size

4.4 KB

Accession

0000905148-25-000730

Insider Transaction Report

Form 4
Period: 2025-02-14
Peterson Katharine
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-14$5.42/sh116$6294,419 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1
  • filerCIK 0002022214

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:00 PM ET
Size
4.4 KB